Posted on 2/12/21
Infinity Prices of $80 Million Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (Nasdaq: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic . . .
Posted on 2/12/21
Tufin Announces Fourth Quarter and Full Year 2020 Results
BOSTON & TEL AVIV, Israel--(BUSINESS WIRE)--Tufin (NYSE: TUFN), a company pioneering a policy-centric approach to security and IT operations, today announced financial results for the fourth . . .
Posted on 2/12/21
SQZ Biotech Prices of Public Offering of Common Stock
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies Company (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the pricing of its underwritten public . . .
Posted on 2/12/21
ImmunoGen Reports Recent Progress and 2020 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today reviewed recent progress in . . .
Posted on 2/12/21
Joanna Brougher Authors Second Book “Billion Dollar Patents: Strategies for Finding Opportunities, Generating Value, and Protecting Your Inventions”
BioPharma Law Group, PLLC is pleased to announce that its Principal, Joanna T. Brougher, MPH, Esq., has published her newest book, Billion Dollar Patents: Strategies for Finding . . .
Posted on 2/12/21
Burns & Levinson Wins Summary Judgment for Caffe Nero in Covid-Related Rent Dispute with Landlord in Suffolk Superior Court
Burns & Levinson won a precedential Suffolk Superior Court decision on February 8 granting partial summary judgment
Posted on 2/12/21
Conformis Prices of $85 Million Underwritten Offering of Common Stock
BILLERICA, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has priced an underwritten public offering of 80,952,381 shares of its . . .
Posted on 2/12/21
Jounce Therapeutics Appoints Luisa Salter-Cid, Ph.D., to its Board of Directors
Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies
Posted on 2/12/21
Service Properties Trust Completes Transfer of 78 Hotels to Sonesta
NEWTON, Mass.--(BUSINESS WIRE)--Service Properties Trust (Nasdaq: SVC), or SVC, today announced that it has completed the transition of branding and management for 78 hotels to subsidiaries . . .
Posted on 2/12/21
Management Matters: Do You Have the Courage to Be a Manager?
My clients who are managers often laugh at the joke that in exchange for being paid the ‘big bucks,’ they have to make hard decisions. It . . .
Posted on 2/12/21
Affiliate of Paceline Equity Partners Acquires Commercial Loan Secured by Sheraton Needham Hotel in Boston Metro Area
DALLAS--(BUSINESS WIRE)--An affiliate of Paceline Equity Partners, LLC, a Dallas-based private equity manager, today announced that it has acquired a commercial loan secured by a senior . . .
Posted on 2/12/21
Altra Reports Fourth-Quarter 2020 Results
BRAINTREE, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Altra Industrial Motion Corp. (Nasdaq: AIMC), a leading global manufacturer and supplier of motion control, power transmission and . . .
Posted on 2/12/21
Sensata Technologies to Acquire Xirgo Technologies
SWINDON, United Kingdom--(BUSINESS WIRE)--Sensata Technologies (NYSE: ST), a leading industrial technology company and provider of sensor-rich solutions that create insight for customers, today announced the acquisition . . .
Posted on 2/12/21
Arch Therapeutics Announces $6.9 Million Private Placement
FRAMINGHAM, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH), developer of novel self-assembling wound care and biosurgical devices, today announced that it . . .
Posted on 2/12/21
Pelosi Expects Stimulus Bill to Pass Before Boosted Unemployment Runs Out
Extended unemployment benefits are set to run out as early as March -- but Nancy Pelosi is confident relief will be here sooner.Millions of Americans have . . .
Posted on 2/12/21
Drama Is Beginning to Unfold at Berkshire Hills Bancorp. Will It Benefit Shareholders?
Life at the $12.8-billion-asset Berkshire Hills Bancorp (NYSE:BHLB) has been anything but dull over the past few years, whether you look at the bank's volatile stock . . .
Posted on 2/12/21
Forget Moderna! This Is a More Lucrative Coronavirus Stock
In the first 10 years of Moderna's (NASDAQ:MRNA) existence, the pharmaceutical and biotechnology company didn't launch a single product onto the market. That changed last December . . .
Posted on 2/12/21
iRobot's Earnings Crush Expectations: 5 Metrics You Should See
iRobot (NASDAQ:IRBT) reported strong fourth-quarter 2020 results after the market close on Wednesday.Shares soared 9.1% in Wednesday's after-hours trading. We can attribute the market's enthusiasm in . . .
Posted on 2/12/21
Hasbro's New TV and Film Segment Show Early Signs of a Rebound
Toy maker Hasbro (NASDAQ:HAS) turned in its final report card for 2020, capping off a challenging year with a solid showing. Year over year, revenue and . . .
Posted on 2/12/21
3 Stocks Warren Buffett Should Buy in 2021
Warren Buffett has gained international recognition for his ability to beat the stock market by focusing on fundamentals. Widely considered the greatest investor of all time, . . .
Posted on 2/12/21
Codiak Prices of $57.8 Million Public Offering of Common Stock
CAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as . . .
Posted on 2/12/21
Oncorus Prices of Public Offering of Common Stock
CAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Oncorus, Inc. (Nasdaq: ONCR), a clinical stage biopharmaceutical company developing next-generation, systemically active viral immunotherapies to transform outcomes . . .
Posted on 2/12/21
Decibel Therapeutics Prices of IPO
BOSTON, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve . . .
Posted on 2/12/21
Mercury Recognized as One of Massachusetts' Fastest-Growing Middle-Market Companies
ANDOVER, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Mercury Systems Inc. (NASDAQ: MRCY, www.mrcy.com), a leader in trusted, secure mission-critical technologies for aerospace and defense, announced . . .
Posted on 2/12/21
Conformis Announces Proposed Public Offering of Common Stock
BILLERICA, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced that it intends to offer shares of its common stock in an . . .
Boston
